Whole cell-based vaccine against pancreatic cancer
- Summary
- This technology is a whole cell-based vaccine that boosts the patient’s immune system for a precision approach to pancreatic cancer treatment.
- Technology Benefits
- Greater potential for effectiveness than chemotherapyPatient-specific therapyCombinatorial design (i.e. dendritic cells, macrophages, whole cancer cells) activates complementary immune-response pathways against a full range of pancreatic cancer antibodiesLimits ability of cancer mutation to circumvent treatment
- Technology Application
- Vaccine for pancreatic cancerVaccine for other cancers with similar cell dynamicsFurther research into immune-cell response and whole-cell based immune-cell engineeringLibrary of various genotypes of immune cells presenting antigens from various whole cancer cellsCombination therapy for cancer in conjunction with chemotherapy and radiation
- Detailed Technology Description
- None
- *Abstract
-
None
- *Inquiry
- Jerry KokoshkaColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
- *IR
- CU16094
- *Principal Investigator
-
- *Publications
- Tech Ventures Reference:IR CU16094Licensing Contact: Jerry Kokoshka
- Country/Region
- USA
For more information, please click Here
